European equities traded in the US as American depositary receipts were climbing sharply late Friday morning, rising 2.45% to 1,423.12 on the S&P Europe Select ADR Index, which is up 2.3% for the week.
From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and financial services company ING Groep (ING), which advanced 8.9% and 7.5%, respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and biopharmaceutical company Grifols (GRFS), which rose 5.9% and 4.4%, respectively.
The decliners from continental Europe were led by internet advertising firm Criteo (CRTO) and telecommunications operator Telefonica (TEF), which fell 11% and 1.5%, respectively. They were followed by furniture maker Natuzzi (NTZ) and oil and gas company TotalEnergies (TTE), which were down 1.2% and 0.4%, respectively.
From the UK and Ireland, the gainers were led by biotech firms Autolus Therapeutics (AUTL) and Trinity Biotech (TRIB), which were up 3.8% and 3.5%, respectively. They were followed by cruise line operator Carnival (CUK) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which increased 3.3% and 3.2%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which dropped 2.1% and 1.4%, respectively. They were followed by tobacco company British American Tobacco (BTI) and telecommunications operator Vodafone Group (VOD), which lost 0.2% and 0.1%, respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。